Janssen Pharmaceuticals Receives 2018 AMGA Distinguished Corporate Partner Award
Alexandria, VA – AMGA awarded the AMGA Distinguished Corporate Partner Award to Janssen Pharmaceuticals, Inc. (Janssen) at AMGA’s 2018 Annual Conference, held at the Phoenix Convention Center in Phoenix.
AMGA presents the Distinguished Corporate Partner Award annually to an industry partner that supports the team model of healthcare delivery and develops programs and services to help medical groups and health systems deliver high-quality, high-value, efficient health care.
“We are pleased to award Janssen for their outstanding partnership and support of AMGA and our members,” said Jerry Penso, M.D., M.B.A., AMGA's president and chief executive officer. “Through Janssen’s contributions, we are able to enhance our members’ efforts to improve the delivery of high-quality, patient-centered health care.”
As a member of the AMGA Chairman’s Circle, Janssen Pharmaceuticals is a Principle Corporate Collaborator for AMGA Foundation’s Together 2 Goal® diabetes campaign.
“Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time,” continued Penso. “Through their support, Janssen is helping us achieve the goal of our Together 2 Goal® campaign of improving care for one million people with Type 2 diabetes. We thank them and look forward to their continued partnership.”
More information on the AMGA Distinguished Corporate Partner Award can be found here.
###
About AMGA
AMGA is a trade association leading the transformation of health care in America. Representing multispecialty medical groups and integrated systems of care, we advocate, educate, innovate and empower our members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of medical groups’ recognized excellence in the delivery of coordinated, high-quality, cost-effective care. More than 175,000 physicians practice in our member organizations, delivering care to one in three Americans.